Title: Research on liver regeneration as an answer to the shortage of donors for liver transplantation
Abstract: Hepatology ResearchVolume 44, Issue 9 p. 944-946 Editorial Research on liver regeneration as an answer to the shortage of donors for liver transplantation Artur Cieślar-Pobuda, Artur Cieślar-Pobuda Department of Clinical & Experimental Medicine (IKE), Division of Cell Biology, Integrative Regenerative Medicine Center (IGEN), Linköping University, Linkoping, Sweden Biosystems Group, Institute of Automatic Control, Silesian University of Technology, Gliwice, PolandSearch for more papers by this authorEmilia Wiechec, Emilia Wiechec Department of Clinical & Experimental Medicine (IKE), Division of Cell Biology, Integrative Regenerative Medicine Center (IGEN), Linköping University, Linkoping, SwedenSearch for more papers by this author Artur Cieślar-Pobuda, Artur Cieślar-Pobuda Department of Clinical & Experimental Medicine (IKE), Division of Cell Biology, Integrative Regenerative Medicine Center (IGEN), Linköping University, Linkoping, Sweden Biosystems Group, Institute of Automatic Control, Silesian University of Technology, Gliwice, PolandSearch for more papers by this authorEmilia Wiechec, Emilia Wiechec Department of Clinical & Experimental Medicine (IKE), Division of Cell Biology, Integrative Regenerative Medicine Center (IGEN), Linköping University, Linkoping, SwedenSearch for more papers by this author First published: 16 September 2014 https://doi.org/10.1111/hepr.12265Citations: 10Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1Klein AS, Messersmith EE, Ratner LE, Kochik R, Baliga PK, Ojo AO. Organ donation and utilization in the United States, 1999–2008. Am J Transplant 2010; 10: 973–986. 2Venook AP, Papandreou C, Furuse J, de Guevara LL. The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective. Oncologist 2010; 15 (Suppl 4): 5–13. 3Altekruse SF, McGlynn KA, Reichman ME. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol 2009; 27: 1485–1491. 4Yagi H, Soto-Gutierrez A, Kitagawa Y. Whole-organ re-engineering: a regenerative medicine approach in digestive surgery for organ replacement. Surg Today 2013; 43: 587–594. 5Dindoost P, Jazayeri SM, Alavian SM. Hepatitis B immune globulin in liver transplantation prophylaxis: an update. Hepat Mon 2012; 12: 168–176. 6Starzl TE, Marchioro TL, Vonkaulla KN, Hermann G, Brittain RS, Waddell WR. Homotransplantation of the Liver in Humans. Surg Gynecol Obstet 1963; 117: 659–676. 7Garg M, Jones RM, Vaughan RB, Testro AG. Intestinal transplantation: current status and future directions. J Gastroenterol Hepatol 2011; 26: 1221–1228. 8Ekser B, Gridelli B, Tector AJ, Cooper DK. Pig liver xenotransplantation as a bridge to allotransplantation: which patients might benefit? Transplantation 2009; 88: 1041–1049. 9Michalopoulos GK. Liver regeneration. J Cell Physiol 2007; 213: 286–300. 10Taub R. Liver regeneration: from myth to mechanism. Nat Rev Mol Cell Biol 2004; 5: 836–847. 11Schneider A, Attaran M, Meier PN et al. Hepatocyte transplantation in an acute liver failure due to mushroom poisoning. Transplantation 2006; 82: 1115–1116. 12Ogawa S, Miyagawa S. Potentials of regenerative medicine for liver disease. Surg Today 2009; 39: 1019–1025. 13Hughes RD, Mitry RR, Dhawan A. Current status of hepatocyte transplantation. Transplantation 2012; 93: 342–347. 14Habibullah CM, Syed IH, Qamar A, Taher-Uz Z. Human fetal hepatocyte transplantation in patients with fulminant hepatic failure. Transplantation 1994; 58: 951–952. 15Lagasse E, Connors H, Al-Dhalimy M et al. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med 2000; 6: 1229–1234. 16Kuo TK, Hung SP, Chuang CH et al. Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells. Gastroenterology 2008; 134: 2111–2121. 21 e1-3. 17Yadav N, Kanjirakkuzhiyil S, Kumar S et al. The therapeutic effect of bone marrow-derived liver cells in the phenotypic correction of murine hemophilia A. Blood 2009; 114: 4552–4561. 18Khurana S, Mukhopadhyay A. Characterization of the potential subpopulation of bone marrow cells involved in the repair of injured liver tissue. Stem Cells 2007; 25: 1439–1447. 19Vassilopoulos G, Wang PR, Russell DW. Transplanted bone marrow regenerates liver by cell fusion. Nature 2003; 422: 901–904. 20Mukhopadhyay A. Perspective on liver regeneration by bone marrow-derived stem cells-a scientific realization or a paradox. Cytotherapy 2013; 15: 881–892. 21Shiota G, Yasui T. Progress in stem cell biology in regenerative medicine for liver disease. Hepatol Res 2012; 42: 15–21. 22Espejel S, Roll GR, McLaughlin KJ et al. Induced pluripotent stem cell-derived hepatocytes have the functional and proliferative capabilities needed for liver regeneration in mice. J Clin Invest 2010; 120: 3120–3126. 23Yi F, Liu GH, Izpisua Belmonte JC. Human induced pluripotent stem cells derived hepatocytes: rising promise for disease modeling, drug development and cell therapy. Protein Cell 2012; 3: 246–250. 24Cayo MA, Cai J, Delaforest A et al. JD induced pluripotent stem cell-derived hepatocytes faithfully recapitulate the pathophysiology of familial hypercholesterolemia. Hepatology 2012; 56: 2163–2171. 25Iwamuro M, Shiraha H, Nakaji S et al. A preliminary study for constructing a bioartificial liver device with induced pluripotent stem cell-derived hepatocytes. Biomed Eng Online 2012; 11: 93. 26Li YS, Harn HJ, Hsieh DK et al. Cells and materials for liver tissue engineering. Cell Transplant 2013; 22: 685–700. 27Ohashi K. Liver tissue engineering: the future of liver therapeutics. Hepatol Res 2008; 38 (Suppl 1): S76–87. 28Soto-Gutierrez A, Zhang L, Medberry C et al. A whole-organ regenerative medicine approach for liver replacement. Tissue Eng Part C Methods 2011; 17: 677–686. 29Keane TJ, Londono R, Turner NJ, Badylak SF. Consequences of ineffective decellularization of biologic scaffolds on the host response. Biomaterials 2012; 33: 1771–1781. Citing Literature Volume44, Issue9September 2014Pages 944-946 ReferencesRelatedInformation
Publication Year: 2014
Publication Date: 2014-09-01
Language: en
Type: editorial
Indexed In: ['crossref', 'pubmed']
Access and Citation
Cited By Count: 9
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot